StonvexLoading…
StonvexCore line items from AES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.18B | $12.23B | $9.13B | $5.78B |
Operating Income | $242.00M | $75.00M | $344.00M | $17.00M |
Net Income | $487.00M | $910.00M | $590.00M | $-49.00M |
EPS (Diluted) | $0.68 | $1.26 | $0.81 | $-0.08 |
Total Assets | $52.82B | $51.77B | $50.78B | $48.54B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.60B | $1.38B | $1.76B | $1.35B |
Free Cash Flow OCF − CapEx | $-565.00M | $-1.62B | $-1.58B | $-1.06B |
Shares Outstanding | 713.14M | 712.20M | 712.12M | 711.92M |